InflaRx N.V. operates as a clinical-stage biopharmaceutical company. The Company discovers and develops monoclonal antibodies drugs for the treatment of inflammatory diseases. InflaRx serves patients worldwide.
more
Refresh
Request Primer
No publications yet
No AI primers are available right now. Create one using Smartkarma AI.